DOES ADJUVANT CHEMOTHERAPY BENEFIT HIGH-RISK STAGE 2 COLON CANCER: A NOMOGRAM TO PREDICT REDUCTION IN 5-YEAR MORTALITY RISK WITH ADJUVANT CHEMOTHERAPY.

被引：0
|
作者：
Graham, A. E.
Sparks, A.
Umapathi, B.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2019年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P36
引用
收藏
页码：E121 / E122
页数：2
相关论文
共 50 条
  • [11] Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study
    Butare, Annmarie
    Sutton, Tia
    Kantzler, Elizabeth
    Kennedy, Katie N.
    Tumin, Dmitry
    Honaker, Michael D.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [12] Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
    Cho, Jung Rae
    Lee, Keun-Wook
    Oh, Heung-Kwon
    Kim, Jin Won
    Kim, Ji-Won
    Kim, Duck-Woo
    Kim, Jee Hyun
    Kang, Sung-Bum
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 102 (05) : 271 - 280
  • [13] Elevated Carcinoembryonic Antigen Warrants Adjuvant Chemotherapy in High-risk Stage II Colon Cancer
    Wilson, Tanner B.
    Narayanan, Sowmya
    Khan, Sidrah
    Althans, Alison R.
    Paniccia, Alessandro
    Zureikat, Amer H.
    Kaltenmeier, Christof
    Lee, Kenneth K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 380 - 380
  • [14] Microsatellite Status Predicts Effectiveness of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
    Krishnamurty, Devi Mukkai
    Park, Yu-Soon A.
    Tashjian, Nara
    Aurit, Sarah J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S65 - S66
  • [15] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [16] Adjuvant chemotherapy for high-risk operable breast cancer
    Buzdar, Aman U.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1642 - 1644
  • [17] The rationale for adjuvant chemotherapy for high-risk prostate cancer
    Kent, EC
    Hussain, MHA
    CURRENT OPINION IN UROLOGY, 2003, 13 (02) : 123 - 131
  • [18] Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
    Liu, Lin-Lin
    Xiang, Zuo-Lin
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [19] Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer
    Verhoeff, S. R.
    van Erning, F. N.
    Lemmens, V. E. P. P.
    de Wilt, J. H. W.
    Pruijt, J. F. M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (01) : 187 - 193
  • [20] Adjuvant Chemotherapy Use and Outcomes of Patients With High-Risk Versus Low-Risk Stage II Colon Cancer
    Kumar, Aalok
    Kennecke, Hagen F.
    Renouf, Daniel J.
    Lim, Howard J.
    Gill, Sharlene
    Woods, Ryan
    Speers, Caroline
    Cheung, Winson Y.
    CANCER, 2015, 121 (04) : 527 - 534
12345